Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

100%(4 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

20%

Ph phase_4

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 4Post-market surveillance

4(80.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 44 (80.0%)

N/A1 (20.0%)

Trials by Status

completed480%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

NCT02362373

Clinical Trials (5)

Showing 5 of 5 trials

NCT01539720Not Applicable

Levonorgestrel Intrauterine System For Emergency Contraception

Completed

NCT04814927Phase 4

Impact of Contraceptives on Cervico-Vaginal Mucosa

Completed

NCT03317795Phase 4

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Completed

NCT01594476Phase 4

Early Postpartum Intrauterine Device (IUD) Placement

Terminated

NCT02362373Phase 4

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5